Efamarine is a patented fatty acid combination of 65% Efamol Evening Primrose Oil (omega-6) and 35% marine fish oil (omega-3), a ratio clinically proven to be most effective for general, cardiovascular and joint health. Several clinical trials have been conducted using Efamarine. With the significant role EFAs have in the structure and function of every cell, it is apparent that an EFA deficiency may lead to abnormalities in almost every body system.

Usage: Where there are essential fatty acids deficiencies and to help support general, cardiovascular and joint health.